Nucleonics

Developing RNAi therapeutics for Hepatitis B and C, using eiRNA technology

placeLanghorne, Pennsylvania, United States calendar_todayFounded 2001 language nucleonicsinc.com

Innovation

20 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 269 times.

YearFilings
20131
20191

Investor mix

8 investors on record.

Investor typeCountShare
Venture capital675%
Bank & private debt113%
Other / undisclosed113%
Coming soon